Skip to main content
Myles Greenberg, MD, Emergency Medicine, Salt Lake City, UT

MylesDavidGreenbergMDMBA

Emergency Medicine Salt Lake City, UT

President & CEO, Alucent Biomedical, Inc.

Dr. Greenberg is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Greenberg's full profile

Already have an account?

  • Office

    675 S Arapeen Dr
    Ste 102
    Salt Lake City, UT 84108
    Phone+1 385-722-2335

Education & Training

  • UPMC Medical Education (Pittsburgh)
    UPMC Medical Education (Pittsburgh)Residency, Emergency Medicine, 1993 - 1996
  • Yale School of Medicine
    Yale School of MedicineClass of 1993

Certifications & Licensure

  • GA State Medical License
    GA State Medical License 2021 - 2026
  • IL State Medical License
    IL State Medical License 2016 - 2026
  • MA State Medical License
    MA State Medical License 1996 - 2026
  • MD State Medical License
    MD State Medical License 2021 - 2026
  • NY State Medical License
    NY State Medical License 2015 - 2026
  • UT State Medical License
    UT State Medical License 2014 - 2026
  • VA State Medical License
    VA State Medical License 2021 - 2026
  • American Board of Emergency Medicine Emergency Medicine
  • Join now to see all

Publications & Presentations

PubMed

Press Mentions

  • The Doctors Are Not All Right
    The Doctors Are Not All RightJune 23rd, 2021
  • Stanford Surgeon Venita Chandra Joins Alucent Biomedical Scientific Advisory Board as Company Enters Arteriovenous
    Stanford Surgeon Venita Chandra Joins Alucent Biomedical Scientific Advisory Board as Company Enters ArteriovenousDecember 8th, 2020
  • Alucent Biomedical Announces $35 Million Series B Financing Led by a Multinational Strategic Investor
    Alucent Biomedical Announces $35 Million Series B Financing Led by a Multinational Strategic InvestorOctober 1st, 2020
  • Join now to see all

Industry Relationships

  • President and CEO, Alucent Medical, Inc.2017 - Present
  • Board of Directors, CareWell Urgent Care2012 - Present
  • Chief Development Officer, IntegraMed Fertility2015 - 2016
  • Partner, HealthInvest Equity PartnersHealthcare Services private equity firm2014 - 2016
  • Board of Directors, Dicom Grid2011 - 2016
  • Partner, CHL Medical PartnersHealthcare Venture Capital firm2004 - 2016
  • Board of Directors, Mevion Medical Systems2009 - 2015
  • Board of Directors, Vertos Medical2009 - 2015
  • Board of Directors, Vascular PathwaysAcquired by C.R. Bard, Inc.2010 - 2014
  • Board of Directors, Millennium Pharmacy Systemsacquired by PharMerica, Inc.2005 - 2014
  • Board of Directors, Oriel Therapeuticsacquired by Novartis / Sandoz2007 - 2010